Cargando…

Extracorporeal immunoadsorption of circulating specific serum factors in cancer patients.

Circulating serum factors have been said to abrogate the effects of immune response in cancer, i.e. "blocking" and "antigenic inhibition". The aim of this investigation was to isolate such specific factors in a purified and native state. F(ab)2 fragments isolated from hypernephro...

Descripción completa

Detalles Bibliográficos
Autores principales: Langvad, E., Hydén, H., Wolf, H., Kroeigaard, N.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1975
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2025021/
https://www.ncbi.nlm.nih.gov/pubmed/1220760
_version_ 1782136679495106560
author Langvad, E.
Hydén, H.
Wolf, H.
Kroeigaard, N.
author_facet Langvad, E.
Hydén, H.
Wolf, H.
Kroeigaard, N.
author_sort Langvad, E.
collection PubMed
description Circulating serum factors have been said to abrogate the effects of immune response in cancer, i.e. "blocking" and "antigenic inhibition". The aim of this investigation was to isolate such specific factors in a purified and native state. F(ab)2 fragments isolated from hypernephroma were insolubilized on the surfaces of an extracorporeal perfusion chamber which was inserted into the circulation by means of an arterio-venous shunt. As a result, 3 proteins not present in normal serum were isolated and eluted for further study. In immunoelectrophoresis the 3 proteins were specifically precipitated by heterolgous (rabbit) antihypernephroma serum but not by anti-serum directed against normal serum components. Moreover C9 components, C3 activator and C3 were isolated in the chamber, the latter complement factor in large concentrations. This further sustained that specific antigen-antibody reactions had occurred in the chamber. One of the 2 patients studied were perfused for 60 h and 40 min. During this period 450 litres of blood were brought into intimate contact with the immunoadsorbent. Proteins in amounts sufficient for immunochemical analysis were isolated within 3 h. IMAGES:
format Text
id pubmed-2025021
institution National Center for Biotechnology Information
language English
publishDate 1975
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-20250212009-09-10 Extracorporeal immunoadsorption of circulating specific serum factors in cancer patients. Langvad, E. Hydén, H. Wolf, H. Kroeigaard, N. Br J Cancer Research Article Circulating serum factors have been said to abrogate the effects of immune response in cancer, i.e. "blocking" and "antigenic inhibition". The aim of this investigation was to isolate such specific factors in a purified and native state. F(ab)2 fragments isolated from hypernephroma were insolubilized on the surfaces of an extracorporeal perfusion chamber which was inserted into the circulation by means of an arterio-venous shunt. As a result, 3 proteins not present in normal serum were isolated and eluted for further study. In immunoelectrophoresis the 3 proteins were specifically precipitated by heterolgous (rabbit) antihypernephroma serum but not by anti-serum directed against normal serum components. Moreover C9 components, C3 activator and C3 were isolated in the chamber, the latter complement factor in large concentrations. This further sustained that specific antigen-antibody reactions had occurred in the chamber. One of the 2 patients studied were perfused for 60 h and 40 min. During this period 450 litres of blood were brought into intimate contact with the immunoadsorbent. Proteins in amounts sufficient for immunochemical analysis were isolated within 3 h. IMAGES: Nature Publishing Group 1975-12 /pmc/articles/PMC2025021/ /pubmed/1220760 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Langvad, E.
Hydén, H.
Wolf, H.
Kroeigaard, N.
Extracorporeal immunoadsorption of circulating specific serum factors in cancer patients.
title Extracorporeal immunoadsorption of circulating specific serum factors in cancer patients.
title_full Extracorporeal immunoadsorption of circulating specific serum factors in cancer patients.
title_fullStr Extracorporeal immunoadsorption of circulating specific serum factors in cancer patients.
title_full_unstemmed Extracorporeal immunoadsorption of circulating specific serum factors in cancer patients.
title_short Extracorporeal immunoadsorption of circulating specific serum factors in cancer patients.
title_sort extracorporeal immunoadsorption of circulating specific serum factors in cancer patients.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2025021/
https://www.ncbi.nlm.nih.gov/pubmed/1220760
work_keys_str_mv AT langvade extracorporealimmunoadsorptionofcirculatingspecificserumfactorsincancerpatients
AT hydenh extracorporealimmunoadsorptionofcirculatingspecificserumfactorsincancerpatients
AT wolfh extracorporealimmunoadsorptionofcirculatingspecificserumfactorsincancerpatients
AT kroeigaardn extracorporealimmunoadsorptionofcirculatingspecificserumfactorsincancerpatients